Trump is receiving dexamethasone, a steroid usually given to ...
STAT - 09 Oct 2020Trump has started receiving dexamethasone, a common steroid that has been shown to be helpful in people with severe cases of the disease.
Dexamethasone
Trump has started receiving dexamethasone, a common steroid that has been shown to be helpful in people with severe cases of the disease.
Delivery of Dexamethasone Using Folate-Targeted Au Nanoflowers for Rheumatoid Arthritis Therapy
ACS Publications - 07 May 2025Delivery of Dexamethasone Using Folate-Targeted Au Nanoflowers for Rheumatoid Arthritis Therapy ...
Dexamethasone for the management of CRS Related to teclistamab in patients with relapsed/refractory multiple myeloma | Blood Cancer Journal
Nature - 04 Mar 2025Dexamethasone for the management of CRS Related to teclistamab in patients with relapsed/refractory multiple myeloma | Blood Cancer Journal ...
Subconjunctival dexamethasone implant (Ozurdex®) in the management of refractory Non-Infectious anterior scleritis
SpringerOpen - 06 May 2025Subconjunctival dexamethasone implant (Ozurdex®) in the management of refractory Non-Infectious anterior scleritis ...
Long-term safety of dexamethasone sodium phosphate encapsulated in autologous erythrocytes in pediatric patients with ataxia telangiectasia
Frontiers - 22 Jan 2025Long-term safety of dexamethasone sodium phosphate encapsulated in autologous erythrocytes in pediatric patients with ataxia telangiectasia ...
Dexamethasone Suppression to Identify Hypercortisolism
HCPLive - 30 Apr 2025Dexamethasone Suppression to Identify Hypercortisolism ...
High-Altitude Travel and Altitude Illness | Yellow Book
Centers for Disease Control and Prevention | CDC (.gov) - 23 Apr 2025High-Altitude Travel and Altitude Illness | Yellow Book ...
Myeloma: Does Salvage Transplant Show Benefit?
Medscape - 07 May 2025Myeloma: Does Salvage Transplant Show Benefit? ...
Dexamethasone benefits in multiple myeloma ‘fade into oblivion’ after a couple months
Healio - 28 Oct 2024Dexamethasone benefits in multiple myeloma ‘fade into oblivion’ after a couple months ...
Dexamethasone for paediatric pneumococcal meningitis
The Lancet - 17 Apr 2025Dexamethasone for paediatric pneumococcal meningitis ...
Design of colon-targeted drug delivery of dexamethasone: Formulation and in vitro characterization of solid dispersions
ScienceDirect.com - 30 Jul 2024Design of colon-targeted drug delivery of dexamethasone: Formulation and in vitro characterization of solid dispersions ...
Daratumumab/lenalidomide/dexamethasone in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomes | Leukemia
Nature - 27 Feb 2025Daratumumab/lenalidomide/dexamethasone in transplant-ineligible newly diagnosed myeloma: MAIA long-term outcomes | Leukemia ...
Dexamethasone: a double-edged sword in the treatment of osteoarthritis
Nature - 07 Apr 2025Dexamethasone: a double-edged sword in the treatment of osteoarthritis ...
Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial
Nature - 05 Feb 2025Daratumumab plus bortezomib, lenalidomide and dexamethasone for transplant-ineligible or transplant-deferred newly diagnosed multiple myeloma: the randomized phase 3 CEPHEUS trial ...
Intratympanic administration of dexamethasone attenuates radiation induced damage to middle ear mucosa
Nature - 24 Jan 2025Intratympanic administration of dexamethasone attenuates radiation induced damage to middle ear mucosa ...
Comparative statistical evaluation of greenness, blueness, and whiteness spectrophotometric methods for dexamethasone and chloramphenicol estimation
Nature - 21 Apr 2025Comparative statistical evaluation of greenness, blueness, and whiteness spectrophotometric methods for dexamethasone and chloramphenicol estimation ...
Daratumumab plus lenalidomide/dexamethasone in untreated multiple myeloma: analysis of key subgroups of the MAIA study | Leukemia
Nature - 15 Jan 2025Daratumumab plus lenalidomide/dexamethasone in untreated multiple myeloma: analysis of key subgroups of the MAIA study | Leukemia ...
Ixazomib or Lenalidomide combined with cyclophosphamide and dexamethasone in the treatment of elderly transplant-ineligible newly diagnosed multiple myeloma | Scientific Reports
Nature - 24 Feb 2025Ixazomib or Lenalidomide combined with cyclophosphamide and dexamethasone in the treatment of elderly transplant-ineligible newly diagnosed multiple myeloma | Scientific Reports ...
Distinct pulmonary and systemic effects of dexamethasone in severe COVID-19
Nature - 28 Jun 2024Distinct pulmonary and systemic effects of dexamethasone in severe COVID-19 ...
Safety and efficacy of supraciliary dexamethasone implantation for macular oedema: a preliminary comparative study
Nature - 07 Jan 2025Safety and efficacy of supraciliary dexamethasone implantation for macular oedema: a preliminary comparative study ...